Company Filing History:
Years Active: 2001
Title: Kazuhiro Sanpei: Innovator in Genetic Diagnostics
Introduction
Kazuhiro Sanpei is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of genetic diagnostics, particularly in the diagnosis of spinocerebellar ataxia type 2 (SCA2). His innovative approach has the potential to improve the accuracy of genetic testing for this condition.
Latest Patents
Sanpei holds a patent for a method specifically designed for diagnosing spinocerebellar ataxia type 2. The patent, titled "Method for diagnosing spinocerebellar ataxia type 2 and primers therefor," outlines a process that utilizes PCR technology. This method involves the use of specific primers that hybridize with parts of the nucleotide sequence associated with SCA2. By measuring the number of CAG repeats in the amplified PCR product, the method can distinguish between SCA2 patients and normal individuals, thereby facilitating accurate diagnosis.
Career Highlights
Throughout his career, Kazuhiro Sanpei has focused on advancing genetic research and diagnostics. His work has been instrumental in developing methods that enhance the understanding and diagnosis of genetic disorders. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Sanpei collaborates with fellow researcher Shoji Tsuji, working together to further explore advancements in genetic diagnostics. Their combined expertise enhances the potential for innovative solutions in the field.
Conclusion
Kazuhiro Sanpei's contributions to genetic diagnostics, particularly through his patented method for diagnosing spinocerebellar ataxia type 2, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in genetic testing.